Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by narmacon Feb 05, 2023 9:10am
658 Views
Post# 35267458

British Columbia Securities Commission!!

British Columbia Securities Commission!!What do the Shareholders want to do this week????,,A Zoom meeting among interested parties is essential,,,!!!,,I am thinking we make contact with the BCSC to ensure our rights are respected and protected going forward and the responsibilities of the four separate groups managing Bioasis fulfill their respective duties.  The Senior Managers,,The BoDs,,,,The Medical Advisory Board,,,,and the Scientific Advisory Board,,,,, Comments Appreciated!



https://www.bcsc.bc.ca/about/contact-us


Contact Us

General Information

Reception: 604-899-6500
Inquiries:  604-899-6854 or 1-800-373-6393 (toll free across Canada)
Fax: 604-899-6506

British Columbia Securities Commission (BCSC)
701 West Georgia Street
P.O. Box 10142, Pacific Centre
Vancouver, BC V7Y 1L2

Contact Us

General Information

Reception: 604-899-6500
Inquiries:  604-899-6854 or 1-800-373-6393 (toll free across Canada)
Fax: 604-899-6506

British Columbia Securities Commission (BCSC)
701 West Georgia Street
P.O. Box 10142, Pacific Centre
Vancouver, BC V7Y 1L2


<< Previous
Bullboard Posts
Next >>